{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:20:15Z","timestamp":1789665615530,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1124\/dmd.110.035964","type":"journal-article","created":{"date-parts":[[2010,12,9]],"date-time":"2010-12-09T04:15:44Z","timestamp":1291868144000},"page":"402-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats"],"prefix":"10.1016","volume":"39","author":[{"given":"Catherine W.","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu Cheong","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasinda H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.035964_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0009-9236(99)90084-X","article-title":"The effect of age on the pharmacokinetics and pharmacodynamics of midazolam","volume":"65","author":"Albrecht","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.035964_bib2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","article-title":"Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration","volume":"30","author":"Bartels","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1124\/dmd.110.035964_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1681\/ASN.V94699","article-title":"The aging kidney: insights from experimental studies","volume":"9","author":"Baylis","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.110.035964_bib4","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1038\/sj.ejcn.1601025","article-title":"Fat and protein redistribution with aging: metabolic considerations","volume":"54","author":"Beaufr\u00e8re","year":"2000","journal-title":"Eur J Clin Nutr"},{"key":"10.1124\/dmd.110.035964_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1476-5381.1986.tb10199.x","article-title":"Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system","volume":"87","author":"Brown","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1022844517200","article-title":"Use of M1\u2013M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system","volume":"28","author":"Bymaster","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1124\/dmd.110.035964_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.amjopharm.2004.12.005","article-title":"Pharmacokinetics in older persons","volume":"2","author":"Cusack","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1124\/dmd.110.035964_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/026988110001400301","article-title":"Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat","volume":"14","author":"Dronfield","year":"2000","journal-title":"J Psychopharmacol"},{"key":"10.1124\/dmd.110.035964_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2165\/00003088-200342150-00005","article-title":"Clinical pharmacokinetics of galantamine","volume":"42","author":"Farlow","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.110.035964_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2004.11.042","article-title":"Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits","volume":"1033","author":"Geerts","year":"2005","journal-title":"Brain Res"},{"key":"10.1124\/dmd.110.035964_bib12","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1096\/fasebj.2.7.3280378","article-title":"Age-related nephropathy in laboratory rats","volume":"2","author":"Goldstein","year":"1988","journal-title":"FASEB J"},{"key":"10.1124\/dmd.110.035964_bib13","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1517\/17425255.4.10.1321","article-title":"ADME-tox issues for the elderly","volume":"4","author":"Hilmer","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.110.035964_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1476-5381.1992.tb14482.x","article-title":"Pharmacokinetic-EEG effect relationship of midazolam in aging BN\/BiRij rats","volume":"107","author":"Hovinga","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-008-0499-1","article-title":"Plasma esterases and inflammation in ageing and frailty","volume":"64","author":"Hubbard","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2165\/00003088-200241100-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors","volume":"41","author":"Jann","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.110.035964_bib17","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bjp.0704944","article-title":"Impact of ageing on the antinociceptive effect of reference analgesics in the Lou\/c rat","volume":"137","author":"Jourdan","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","article-title":"Pharmacokinetics and drug metabolism in the elderly","volume":"41","author":"Klotz","year":"2009","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.110.035964_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-2999(99)00741-4","article-title":"Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats","volume":"386","author":"Kosasa","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.110.035964_bib21","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0091270005280297","article-title":"Aging and clinical pharmacology: implications for antidepressants","volume":"45","author":"Lotrich","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","article-title":"Aging biology and geriatric clinical pharmacology","volume":"56","author":"McLean","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.110.035964_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1358\/mf.2000.22.8.701373","article-title":"Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro","volume":"22","author":"Ogura","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib25","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/j.1552-4604.1993.tb01945.x","article-title":"Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects","volume":"33","author":"Ohnishi","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib26","series-title":"Neurodegeneration Methods and Protocols","first-page":"237","article-title":"Biochemical measurement of cholinesterase activity","author":"Padilla","year":"1999"},{"key":"10.1124\/dmd.110.035964_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0197-4580(84)90067-8","article-title":"Cholinergic drug effects and brain muscarinic receptor binding in aged rats","volume":"5","author":"Pedigo","year":"1984","journal-title":"Neurobiol Aging"},{"key":"10.1124\/dmd.110.035964_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0091270003251853","article-title":"Galantamine population pharmacokinetics in patients with Alzheimer's disease: modeling and simulations","volume":"43","author":"Piotrovsky","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.clpt.6100226","article-title":"The current state of knowledge on age, sex, and their interactions on clinical pharmacology","volume":"82","author":"Schwartz","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.035964_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00228-007-0422-1","article-title":"The clinical implications of ageing for rational drug therapy","volume":"64","author":"Shi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/dmd.110.035964_bib31","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMe078023","article-title":"Clinical trials in the elderly\u2014a concept comes of age","volume":"356","author":"Siu","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.110.035964_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-172X.2009.01756.x","article-title":"Time for a change to assess and evaluate body temperature in clinical practice","volume":"15","author":"Sund-Levander","year":"2009","journal-title":"Int J Nurs Pract"},{"key":"10.1124\/dmd.110.035964_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clpt.2006.02.004","article-title":"Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[11C]verapamil and positron emission tomography","volume":"79","author":"Toornvliet","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.110.035964_bib34","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.exger.2004.05.011","article-title":"Drug therapy in the elderly","volume":"39","author":"Turnheim","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1124\/dmd.110.035964_bib35","first-page":"961","article-title":"Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients","volume":"3","author":"Villesen","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1124\/dmd.110.035964_bib36","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1093\/geronj\/46.3.B87","article-title":"Concerns about rodent models for research","volume":"46","author":"Weindruch","year":"1991","journal-title":"J Gerontol Biol Sci"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.035964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:39:32Z","timestamp":1739903972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624057064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0090955624057064"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.035964","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and Pharmacodynamic Properties of Cholinesterase Inhibitors Donepezil, Tacrine, and Galantamine in Aged and Young Lister Hooded Rats","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.035964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}